Login / Signup

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis.

Fredrik Nils AlbachChristian GeierChristian KeicherMaximilian G PoschStephan J SchreiberGerald GrützLevent AkyüzXiaodong LuoAnnaig Le-HalperePhilippe TruffinetFrank Wagner
Published in: Neurology and therapy (2024)
NCT02282826, NCT02977533, NCT02313285.
Keyphrases
  • monoclonal antibody
  • multiple sclerosis
  • white matter